These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 3570375)
1. H-2-specific antibodies induced by injection of syngeneic leukemia cells. Schmidt W Immunogenetics; 1987; 25(4):215-21. PubMed ID: 3570375 [TBL] [Abstract][Full Text] [Related]
2. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia. Schmidt W; Festenstein H Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849 [TBL] [Abstract][Full Text] [Related]
3. Resistance to cellular immune response in AKR leukemias. Schäfer A; Schmidt W Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771 [TBL] [Abstract][Full Text] [Related]
4. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens. Green WR; Nowinski RC; Henney CS J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575 [TBL] [Abstract][Full Text] [Related]
5. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control. Green WR J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409 [TBL] [Abstract][Full Text] [Related]
6. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. Green WR; Nowinski RC; Henney CS J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211 [No Abstract] [Full Text] [Related]
7. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor. Green WR; Brown MA Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207 [TBL] [Abstract][Full Text] [Related]
8. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
9. Variation of expression of histocompatibility antigens on tumor cells: absence of H-2Kk-gene products from a gross-virus-induced leukemia in BALB.K. Schmidt W; Leben L; Atfield G; Festenstein H Immunogenetics; 1981; 14(3-4):323-39. PubMed ID: 7333657 [TBL] [Abstract][Full Text] [Related]
10. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. Manjunath R; Graziano RF; Green WR J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407 [TBL] [Abstract][Full Text] [Related]
11. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone. Green WR Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206 [TBL] [Abstract][Full Text] [Related]
12. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype. Green WR J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410 [TBL] [Abstract][Full Text] [Related]
13. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias. Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124 [TBL] [Abstract][Full Text] [Related]
14. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224 [TBL] [Abstract][Full Text] [Related]
16. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation. Wustrow TP; Good RA Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600 [TBL] [Abstract][Full Text] [Related]
17. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus. Plata F; Lilly F J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655 [TBL] [Abstract][Full Text] [Related]
18. Serological and immunochemical studies of H-2 allospecificities on K36, a syngeneic tumour of AKR. Schmidt W; Festenstein H J Immunogenet; 1980 Feb; 7(1):7-17. PubMed ID: 6154751 [TBL] [Abstract][Full Text] [Related]
19. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody. Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764 [TBL] [Abstract][Full Text] [Related]
20. Correlation between quantitative expression of H-2K, H-2D and MuLV antigens on spontaneous AKR lymphomas. Oudshoorn-Snoek M; Demant P Int J Cancer; 1986 Feb; 37(2):303-10. PubMed ID: 3002991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]